Last $87.64 USD
Change Today +0.48 / 0.55%
Volume 3.6M
CELG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
NASDAQ GM
As of 8:10 PM 07/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George S. Golumbeski Ph.D.

Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee, Enanta Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 4 different industries.

See Board Relationships
57--

Background*

Dr. George S. Golumbeski, Ph.D. has been Senior Vice President of Business Development at Celgene Corporation since 2009. Dr. Golumbeski is responsible for business development, M&A, licensing, and partnership activities at Celgene Corporation. He has nearly 20 years' senior executive and business development experience in the pharmaceutical and biotechnology industry. He served as the Chief Executive Officer of Nabriva Therapeutics AG from July 2008 to March 2009. Prior ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: 908-673-9001

Board Members Memberships*

Former Director
2011-Present
Director
2014-Present
Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

BA
University of Virginia
PhD
University of Wisconsin - Madison
Post-Doctoral Training
University of Colorado–Boulder

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $87.64 USD +0.48

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.